This activity is intended for physicians, physician assistants, advanced practice nurses, general practitioners and other health care professionals involved in the treatment and management of patients who have or are at risk of HIV infection.
Upon completion of the program, participants should be able to:
Release Date: June 7, 2019
Expiration Date: June 7, 2020
Estimated time to complete each Module: 30-45 minutes per module
Media: Web
Richard A. Elion, MD
Associate Professor of Clinical Medicine
George Washington University Medical Center
Washington, DC
Ian Frank, MD
Professor of Medicine
Director, Clinical Therapeutics Program
Penn Center for AIDS Research
Perelman School of Medicine at the University of
Pennsylvania
Philadelphia, Pennsylvania
Wilbert Jordan, MD
Medical Director,
Charles Drew Medical Center
Los Angeles, California
William R. Short, MD, MPH
Associate Professor of Medicine
Associate Professor of Obstetrics and Gynecology
Division of Infectious Diseases
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania
Antonio E. Urbina, MD
Medical Director
Institute for Advanced Medicine
Mt. Sinai, St. Luke's and Mt. Sinai Roosevelt Hospitals
New York, New York
|
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and ViralEd, Inc. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians. |
Module 1 (Early Diagnosis and Linkage to Care):
The Annenberg Center for Health Sciences
at Eisenhower designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Module 2 (Addressing Treatment Barriers to Rapid ARV Therapy):
The Annenberg Center for Health Sciences
at Eisenhower designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Module 3 (Guidelines and Data Supporting Rapid ART):
The Annenberg Center for Health Sciences
at Eisenhower designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Module 4 (Individualizing the Management and Treatment of Rapid ARV Therapy):
The Annenberg Center for Health Sciences
at Eisenhower designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Annenberg Center for Health Sciences at Eisenhower requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to the Annenberg Center for Health Sciences at Eisenhower policy. The Annenberg Center for Health Sciences at Eisenhower is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:
Richard Elion, MD
• Consulting Fees: Gilead, ViiV
• Fees for Non-CME/CE Services Received Directly from a Commercial Interest or Their Agents (Speakers Bureau): Gilead, ViiV
• Contracted Research: Gilead, ViiV
Ian Frank, MD
• Consulting Fees: ViiV, Gilead
• Contracted Research: Janssen
Wilbert Jordan, MD:
• Consulting Fees: ViiV, Gilead
• Contracted Research: Pfizer, Janssen, Gilead, TaiMed
William Short, MD
• Consulting Fees: ViiV, Janssen
Antonio Urbina, MD:
• Consulting Fees: Gilead, ViiV, Merck
The PIM planners and managers have nothing to disclose.
Charles E. Willis, Director of Continuing Education, Amanda Sewell, MBA, Manager of Continuing Education and Melissa Velasquez, Accreditation Specialist from the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.
There are no fees for participating and receiving CME credit for this activity. During the period, June 7, 2019 through June 7, 2020, participants must read the learning objectives and faculty disclosures and study the educational activity.
PIM supports Green CME by offering your Request for Credit online. If you wish to received acknowledgment of completing this activity, please complete the post-test and evaluation on http://www.cmeuniversity.com/. On the navigation menu, click on "Find Post-test/Evaluation by Course" and search by course ID 14386. Upon registering and successfully completing the post-test with a score of 70% or better and the activity evaluation, your certificate will be made available immediately. Processing credit requests online will reduce the amount of paper used by nearly 100,000 sheets per year.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
This program requires a modern web browser (Internet Explorer 7+, Mozilla Firefox, Apple Safari, Google Chrome). Certain educational activities may require additional software to view multimedia, presentation, or printable version of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player and Real Networks Real One Player.
·
·
For CME Accreditation Questions, please click HERE
This activity is supported by an independent educational grant from Janssen Therapeutics, Division of Janssen Products, LP
Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and ViralEd, Inc., in collaboration with Postgraduate Institute for Medicine.
